Palisade Bio, Inc.
PALI
$2.14
-$0.01-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -169.66% | -83.78% | -16.23% | 20.18% | 16.43% |
| Total Depreciation and Amortization | -66.67% | -33.33% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -100.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,989.86% | 952.50% | 395.53% | -4.33% | -66.38% |
| Change in Net Operating Assets | -61.35% | 227.62% | 17.83% | -60.12% | 104.01% |
| Cash from Operations | -88.22% | -9.32% | 11.04% | 19.70% | 20.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 10.63% | 10.63% | 24.88% | 9.43% | 15.33% |
| Issuance of Common Stock | 3,035.84% | 1,546.62% | 1,140.62% | 27.85% | -46.28% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -175.68% | -26.42% | -21.11% | 12.49% | 54.02% |
| Cash from Financing | 3,601.02% | 1,788.10% | 1,303.05% | 37.55% | -47.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,117.92% | 3,200.02% | 4,833.55% | 61.32% | -17.54% |